2026 International Spring Forum
April 15, 2026 | 12:00 PM EST
- Home
- Clinical Resources Search
- Overview of BTCEs: Engaging with Bispecific T-Cell Engagers
Engaging with Bispecific T-Cell Engagers
Last Updated: November 20, 2025
An overview of how these agents’ function, their dosing schedules, notable side effects, and the Risk Evaluation and Mitigation Strategies (REMS) requirements for certain agents.
Find Similar Resources:
Immunotherapy
Immunotherapy
Immunotherapy
Immunotherapy
Overview of BTCEs: Bispecific Antibody Therapy Resource Guide
Last Updated: 10/28/2025
Example SOPs and Documents: Transitioning Patients on Bispecific T-Cell Engagers Between Care Settings
Last Updated: 07/01/2025
Example SOPs and Documents: Bispecific T-cell Engager Billing Procedure
Last Updated: 07/01/2025
Up Close with Linvoseltamab
Last Updated: 05/16/2025
Treatment Support Kit
PQI Podcast
PQI Podcast
Patient Education Sheet
Treatment Support Kit: Bispecific Antibody
Last Updated: 12/12/2025
S9 E14: Immunotherapy and the MyMelanoma Project
Last Updated: 12/11/2025
S9 E13: A Season of Gratitude
Last Updated: 12/02/2025
Zongertinib
Last Updated: 11/10/2025